Who is Catalyzing Life Science Startups? New Opportunities for Funding

It's becoming a more frequent occurrence that investors and drugmakers are getting involved in building companies from the ground-up. Third Rock Ventures has a renowned model for "launching" new ventures and Johnson & Johnson's COSAT program sets out to "identify and nurture promising technologies". There are also a few firms that have been successful in raising new funds, most recently Canaan Partners, a Menlo Park based firm raised $600M, a third of which will be dedicated to healthcare companies. The BioCenter and Orrick are therefore bringing together key players involved in building and funding start-ups for a panel discussion.

Our Panel discussions are candid, interactive and informal. We want you to walk away with the real story behind how things work so you can make it happen yourself. This Panel will be followed by a Networking Reception.

PANELISTS

• Wende Hutton, General Partner, Canaan Partners
• Craig Muir, Partner, Third Rock Ventures
• Jeff Calcagno, Senior Director, Emerging Technologies, Corporate Office of Science & Technology (COSAT), Johnson & Johnson
• James Topper, General Partner, Frazier Healthcare
• Lead Facilitator: Scott M. Iyama, Corporate Senior Associate, Orrick, Herrington & Sutcliffe LLP

Agenda